KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $1.1 million.

  • Astrana Health's Net Income towards Common Stockholders fell 9432.59% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 8785.28%. This contributed to the annual value of $45.7 million for FY2024, which is 61.01% up from last year.
  • Per Astrana Health's latest filing, its Net Income towards Common Stockholders stood at $1.1 million for Q3 2025, which was down 9432.59% from $10.2 million recorded in Q2 2025.
  • Astrana Health's Net Income towards Common Stockholders' 5-year high stood at $53.0 million during Q2 2021, with a 5-year trough of -$18.2 million in Q4 2021.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $11.4 million (2022), whereas its average is $10.3 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 55700.9% in 2022, then plummeted by 131993.2% in 2023.
  • Over the past 5 years, Astrana Health's Net Income towards Common Stockholders (Quarter) stood at -$18.2 million in 2021, then surged by 95.14% to -$883000.0 in 2022, then plummeted by 1319.93% to -$12.5 million in 2023, then grew by 4.08% to -$12.0 million in 2024, then skyrocketed by 108.95% to $1.1 million in 2025.
  • Its Net Income towards Common Stockholders was $1.1 million in Q3 2025, compared to $10.2 million in Q2 2025 and $6.2 million in Q1 2025.